Stay updated on ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell
Sign up to get notified when there's something new on the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page.

Latest updates to the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page
- ChecktodayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page has been updated to include specific details about a new clinical trial (ANZUP1802) for non-clear cell renal cell carcinoma, including the treatment drug Cabozantinib and its study parameters. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference50%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check79 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell
Enter your email address, and we'll notify you when there's something new on the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page.